Dynavax Technologies Corp. (DVAX) has provided an announcement. Dynavax Technologies Corporation has appointed Ryan Spencer as the Interim Chief Financial Officer during Kelly MacDonald’s maternity leave, starting April 1, 2024.
Dynavax Technologies Corp. (DVAX) has provided an announcement. Dynavax Technologies Corporation has appointed Ryan Spencer as the Interim Chief Financial Officer during Kelly MacDonald’s maternity leave, starting April 1, 2024.
Dynavax (NASDAQ:DVAX) is a biopharmaceutical player focused on developing and commercializing novel vaccines and immuno-oncology therapeutics. The company’s principal product, a vaccine designed to protect adults against hepatitis B virus,
An update from Dynavax Technologies Corp. (DVAX) is now available. Dynavax Technologies Corporation has transitioned from a sublease with Zymergen Inc. to a new agreement with Metagenomi, Inc. following Zymergen’s
Dynavax (DVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Edward White from H.C. Wainwright reiterated a Buy rating on the stock
וייט מציין כי תחזיות ההכנסות הגבוהות יותר לאחר דוח הרבעון הרביעי הן הסיבה לעליית מחיר היעד. Dynavax מצפה לראות יותר כסף נכנס מאשר יוצא בשנת 2024, והנהלת החברה מתכננת להשתמש